Progesterone Receptor Negative Completed Phase 1 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01276496Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by SurgeryTreatment
NCT01281150Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid TumorsTreatment